Zhang et al. administered BMP4 to CD133+ HCC CSCs and found that a high-dose of exogenous BMP4 promotes their differentiation, resulting in the inhibition of CSC properties [119]. This evidence concerns the gene BMP4 and hepatocellular carcinoma.